Research advance of mitochondrial dysfunction in the mechanism of renal stone formation

doi:10.16352/j.issn.1001-6325.2023.02.306

Abstract

Abstract: The relationship among oxidative stress, inflammations and stone formation has been proved. Mitochondria, as one of the most important organelles in cell, plays an important role in energy supply, oxidative stress, calcium homeostasis and cell programmed death. Mitochondrial dysfunction may accelerate the kidney stone-forming, which may be related to the decreased antioxidant capacity, the activation of inflammatory pathways, the imbalance of intracellular calcium and oxalic acid homeostasis. To clarify the roles of mitochondrial dysfunction in the formation of kidney stones may support the research on pathogenesis of the disease and to provide some potential novel ideas in the prophylactic study of renal stone in future.

Key words: oxidative stress, calcium homeostasis, mitochondria, renal stone, stone formation

CLC Number:

R692.4

HE Qiqi, WU Huang, LI Yuzhuo, BAO Junsheng. Research advance of mitochondrial dysfunction in the mechanism of renal stone formation[J]. Basic & Clinical Medicine, 2023, 43(2): 306-310.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.02.306

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I2/306

References 25

[1]	Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging[J]. Cell, 2005, 120: 483-495.
[2]	Ritov VB, Menshikova EV, He J, et al. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes[J]. Diabetes, 2005,54: 8-14.
[3]	Bai J, Cervantes C, He S, et al. Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice[J]. Commun Biol, 2020,3:1-14.
[4]	Zhong M, He L, Shi Y, et al. Induction of apoptosis in human hepatocellular carcinoma cells by erianin involves a mitochondria-mediated pathway[J]. Curr Top Nutraceut R, 2020,19:261-269.
[5]	Birch-Machin M. The role of mitochondria in ageing and carcinogenesis[J]. Clin Exp Dermatol, 2006,31:548-552.
[6]	Molnar M, Neudecker S, Schröder J. Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy, Kearns-Sayre syndrome, progressive external ophthalmoplegia and MELAS[J]. Neuropathol Appl Neurobiol, 2010,21:432-439.
[7]	Becker Y, Loignon RC, Julien AS, et al. Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations[J]. Sci Rep, 2019,9:1-16
[8]	Wang Z, Ying Z, Bosy-Westphal A, et al. Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure[J]. Am J Clin Nutr, 2010,92: 1369-1377
[9]	Duann P, Lin PH. Mitochondria damage and kidney disease[J]. Mito Dynam Cardiovasc Med, 2017,982: 529-551.
[10]	Yan Y, Xie X. Metabolic compensations in mitochondria isolated from the heart, liver, kidney, brain and white muscle in the southern catfish (Silurus meridionalis) by seasonal acclimation[J]. Comp Biochem Physiol Part A Mol Int Physiol, 2015,183:64-71.
[11]	Indo HP, Davidson M, Yen HC, et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage[J]. Mitochondrion, 2007,7:106-118.
[12]	Abate M, Festa A, Falco M, et al. Mitochondria as playmakers of apoptosis, autophagy and senescence[J]. Semin Cell Dev Biol, 2019,98:139-153
[13]	Asokan D. Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases[J]. Clin Sci, 2018,132:615-626.
[14]	Ceban E, Banov P, Galescu A, et al. Oxidative stress and antioxidant status in patients with complicated urolithiasis[J]. J Med Lif, 2016,9:259-262.
[15]	Zeng X, Xi Y, Jiang W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis: A review[J]. Crit Rev Food Sci, 2019, 13:2125-2135.
[16]	Xiong Y, Hao D, Qin Z, et al. Metformin prevents renal stone formation through an antioxidant mechanism in vitro and in vivo[J]. Oxid Med Cell Longev, 2016,5:AB261-AB263.
[17]	Harrison DJ, Inglis JA, Tolley DA. Percutaneous renal biopsy specimens in stone formers[J]. J Clin Pathol, 1988,41:971-974.
[18]	蒲道静, 郑府, 徐先顺,等. 萝卜硫素干预纳米细菌诱导肾小管上皮细胞凋亡及线粒体自噬相关蛋白的表达[J]. 中国组织工程研究, 2019,23:5503-5507.
[19]	Muthukumar A, Selvam R. Role of glutathione on renal mitochondrial status in hyperoxaluria[J]. Mol Cell Biochem, 1998,185:77-84.
[20]	Yasui T, Okada A, Hamamoto S, et al. Pathophysiology-based treatment of urolithiasis[J]. Int J Urol, 2017,24.32-38.
[21]	Fong-Ngern K, Vinaiphat A, Thongboonker DV. Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate[J]. FASEB J, 2016,31:120-131.
[22]	Kohri K, Yasui T, Okada A, et al. Biomolecular mechanism of urinary stone formation involving osteopontin[J]. Urol Res, 2012,40:623-637.
[23]	Wiener SV, Ho SP, Stoller ML. Beginnings of nephrolithiasis:insights into the past, present and future of Randall's plaque formation research[J]. Curr Opin Nephrol Hy Pertens, 2018,27:236-242
[24]	McMartin KE, Wallace KB. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function[J]. Toxicol Sci, 2005,84:195-200.
[25]	乔逸, 肖河, 樊晓红,等.肾结石患者低枸橼酸尿症代谢相关危险因素分析[J].基础医学与临床,2021,41:1177-1180.